HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

postintensive care syndrome

Also Known As:
post-intensive care syndrome
Networked: 107 relevant articles (3 outcomes, 9 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. COVID-19
2. Delirium
3. Cognitive Dysfunction
4. Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
5. Sleep Wake Disorders

Experts

1. Iwashyna, Theodore J: 5 articles (06/2022 - 12/2014)
2. Williams, Cydni N: 5 articles (04/2022 - 12/2018)
3. Hall, Trevor A: 4 articles (04/2022 - 09/2019)
4. Jackson, James C: 4 articles (11/2020 - 04/2016)
5. Needham, Dale M: 4 articles (11/2020 - 12/2014)
6. McPeake, Joanne: 3 articles (06/2021 - 01/2019)
7. Jeong, Yeon Jin: 3 articles (12/2020 - 12/2018)
8. Kang, Jiyeon: 3 articles (12/2020 - 12/2018)
9. Bienvenu, O Joseph: 3 articles (11/2020 - 02/2012)
10. Hopkins, Ramona O: 3 articles (11/2020 - 12/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to postintensive care syndrome:
1. 4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
2. Hypnotics and Sedatives (Sedatives)IBA
3. ConnectinIBA
4. DexmedetomidineFDA Link
5. Sertraline (Zoloft)FDA LinkGeneric
6. Biomarkers (Surrogate Marker)IBA
7. Tryptophan (L-Tryptophan)FDA Link
8. SteroidsIBA
9. Proteins (Proteins, Gene)FDA Link
10. ParvalbuminsIBA

Therapies and Procedures

1. Critical Care (Surgical Intensive Care)
2. Artificial Respiration (Mechanical Ventilation)
3. Aftercare (After-Treatment)
4. Patient Readmission
5. Palliative Care (Palliative Therapy)